25 mg Proellex
Sponsors
Repros Therapeutics Inc.
Conditions
HealthyUterine Fibroids
Phase 1
Phase 2
Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids
CompletedNCT00882258
Start: 2006-03-31End: 2007-03-31Updated: 2014-07-08
An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext
TerminatedNCT00958893
Start: 2008-06-30End: 2009-08-31Updated: 2014-08-25